Chemomab Therapeutics Announces Year End and Fourth Quarter 2024 Financial Results and ...
Completed Successful FDA End-of-Phase 2 Meeting Following Positive Nebokitug Phase 2 SPRING Trial Resultsin Primary Sclerosing Cholangitis ...